Key result
Non-benign neonatal arrhythmia was associated with higher rates of death and recurrence compared to benign neonatal arrhythmia.
Why the study?
The study was conducted to explore the association between neonatal arrhythmia and mortality and recurrence.
Does non-benign neonatal arrhythmia increase the risk of mortality and recurrence compared to benign neonatal arrhythmia in neonates?
Cohort (n=179)
No
Does non-benign neonatal arrhythmia increase the risk of mortality and recurrence compared to benign neonatal arrhythmia in neonates?
Non-benign neonatal arrhythmia is associated with significantly higher risks of mortality and recurrence compared to benign neonatal arrhythmia, highlighting the need for close follow-up.
Answers are grounded in this paper and cite their sources.
Non-benign neonatal arrhythmias may warrant closer surveillance; this Level 3 finding leaves open causal links and intervention effects.
Objective The aim of the present study was to explore the association between neonatal arrhythmia (NA) and mortality and recurrence. Methods A single-center, retrospective study was performed between January 1, 2015, and December 31, 2019. Neonates with NA were eligible and divided into either benign or non-benign groups. The primary outcomes were mortality and recurrence within 2 to 6 years. Results NA was diagnosed in 189 patients (0.39%) after screening 47,911 hospitalized neonates, and 10 of them did not finish the follow-up. Finally, 179 neonates were included into the final analysis (58 in the non-benign NA and 121 in the benign NA groups). The incidences of death and recurrence for NA were 5.59% (10/179) and 18.44% (33/179). Compared with neonates with benign NA, those neonates with non-benign NA were shown higher rates of death (13.79% vs. 1.65%; odds ratio [OR], 5.73; 95% confidence interval [CI], 1.07–31.01; p = 0.04) and recurrence (44.83% vs. 5.79%; OR, 8.49; 95% CI, 3.12–23.08; p < 0.001). Conclusions Neonates with non-benign NA were shown higher rates of death and recurrence when compared with benign NA. Because of high recurrence, more attention was needed in neonates with non-benign NA after discharge.
No takes yet. Share an insight, caveat, or question.
Ran et al. (2022) conducted a cohort in Neonatal arrhythmia (n=179). Non-benign neonatal arrhythmia vs. Benign neonatal arrhythmia was evaluated on Mortality (OR 5.73, 95% CI 1.07-31.01, p=0.04). Non-benign neonatal arrhythmia was associated with higher rates of death and recurrence compared to benign neonatal arrhythmia.
Synapse has enriched 10 related papers. Consider them for comparative context: